Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (Clodronate)

Calcified Tissue International

Volumn 61, Issue 1, 1997, Pages 59-61

  Teronen, O ^a   Konttinen, Y T ^a,c   Lindqvist, C ^a   Salo, T ^b   Ingman, T ^a   Lauhio, A ^a   Ding, Y ^a   Santavirta, S ^a,c   Valleala, H ^a   Sorsa, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c ORTON Invalid Foundation   (Finland)

Author keywords

Bone destruction; Clodronate Biophosphonate; Collagenase; Inhibition

Indexed keywords

CLODRONIC ACID; COLLAGENASE; COLLAGENASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR;

ARTICLE; BONE DESTRUCTION; DRUG MECHANISM; ENZYME PURIFICATION; HUMAN; HUMAN TISSUE; JAW CYST; MULTIPLE MYELOMA; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; SOFT TISSUE DISEASE;

BONE DISEASES; CLODRONIC ACID; COLLAGEN; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; JAW CYSTS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8;

EID: 0030913514     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900295     Document Type: Article

References (20)

1. Bataille R (1996) Management of myeloma with bisphosphonates (Editorial). N Engl J Med 334:529-530
2. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334:488-493
3. Cundy T, Wattie D, King AR (1996) High-dose pamidronate in the management of resistant Paget's disease. Calcif Tissue Int 58:6-8.
4. Fleisch H (1991) Bisphosphanates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone diseases. Drugs 42:919-944
5. Rosen C, Kessenich CR (1996) Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases. Drugs 51:537-551
6. Birkedal-Hansen H (1988) From tadpole collagenase to family of matrix collagenases. J Oral Pathol 17:445-451
7. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: a review. Crit Rew Oral Biol Med 4:197-250
8. Woessner J (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodelling. Faseb J 5:2145-2154
9. Sorsa T (1989) Human leukocyte collagenase: purification, activation and its role in periodontal collagen degradation. PhD Dissertation, University of Helsinki
10. Konttinen YT, Lindy O, Kemppinen P, Saari H, Suomalainen K, Vauhkonen M, Lindy S, Sorsa T (1991) Collagenase reserves in polymorphonuclear leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. Matrix 11:296-301
11. Teronen O, Salo T, Laitinen J, Törnwall J, Ylipaavalniemi P, Konttinen YT, Hietanen J, Sorsa T (1995) Characterization of interstitial collagenases in jaw cyst walls. Eur J Oral Sci 103: 141-147
12. Teronen O, Salo T, Konttinen YT, Rifkin B, Vernillo A, Ramamurthy NS, Kjeldsen L, Borregaard N, Hietanen J, Sorsa T (1994) Identification and characterization of gelatinases/type IV collagenases in jaw cysts. J Oral Pathol Med 24:78-84
13. Donoff RB, Harper E, Guralnick WC (1972) Collagenolytic activity in keratocysts. J Oral Surg 30:879-884
14. Sorsa T, Ylipaavalniemi P, Suomalainen K, Vauhkonen M, Lindy S (1988) Type-specific degradation of interstitial collagens by human keratocyst capsule collagenase. Med Sci Res 16:1189-1190
15. Suomalainen K, Sorsa T, Golub LM, Ramamurthy NS, Lee H, Uitto V-J, Saari H, Konttinen YT (1992) Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 36: 227-229
16. Reddy MS, Weatherford TW, Smith CA, West BD, Jeffcoat MK, Jacks TM (1995) Alendronate treatment of naturally occurring periodontitis in beagle dog. J Periodontol 66:211-217
17. Frost HM (1983) In: Reckker RR (ed) Histomorphometry: techniques and interpretation. CRC Press, Boca Raton, Florida, pp 109-123
18. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thopson DD, Golub E, Rodan GA (1991) Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105
19. Teronen O, Konttinen YT, Linqvist C, Salo T, Ingman T, Lauhio A, Ding Y, Santavirta S, Sorsa T (1997) Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res, in press.
20. Nakaya H, Osawa G, Aoki M, Iwasaki N, Kamoi K (1997) Effects of bisphosphonate on MMP-1 activity and mRNA expression. J Dent Res 76(Sp Issue) abstr# 2725.